Looks like no one added any tags here yet for you.
ADHD 3 main characteristics
inattention, hyperactivity, impulsivity
comorbidities with ADHD
ODD, CD, tourettes, susbtance use disorder, learning disabilities, mood/anxiety disorders
inattentive subtype DSM IV
6+ of the following sx have persisted for 6mo to a degree that is maladaptive and inconsistent with development levels
fails to give close attn to details or makes careless mistakes
has difficulty sustaining attention in tasks or play activities
does not seem to listen when spoken to directly
does not follow instructions and fails to finish schoolwork, chores, duties
has difficulty organizing tasks and activities
avoids, dislikes or is reluctant to engage in tasks which require sustained mental effort
loses items necessary for tasks or activities often
is easily distracted
is forgetful in daily activities
hyperactivity/impulsivity subtype ADHD DSM IV
6+ of the following sx have persisted for atleast 6mo to a degree that is maladaptive and inconsistent with development level
fidgets with hands or feet or squirms in seat
leaves seat in situations where remaining seated is expected
runs about or climbs excessively in situations in which it is appropriate
has difficulty playing or engaging in leisure activities quietly
is often on the go or acts as if driven by a motor
talks excessively
blurts out answers before q’s have been completed
difficulty waiting their turn
interrupts or intrudes others
explain the time course of ADHD sx
preschool- hyperactive/impulsive
elementary school- inattention starts to become more prominent
adolescence- predominantly inattentive. impulsive behaviours. hyperactivity manifests more as fidgetiness or impatience
adult- inattentive sx predominate. impulsivity may remain problematic even when hyperactivity has diminished
med classes used in ADHD
stimulant, non stimulant, antidepressants, alpha 2 adrenergic agonists
Best evidence of ADHD treatment is what combo
behavioural and pharmacological Tx
moa stimulants (brief)
PFC is hypoactive. inhibitory networks are surpressed bc of low DA/NE
stimulants increase DA/NE by inhibiting reuptake pumps.
low dose stimulant effects
effects NE more than DA
causes less blasts of dopamine in mesolimbic tract= less abuse potential
methylphenidate moa
block NET and DAT (binds allosterically on external cell membraine)
Long acting methylphenidates
Concerta, Biphentin
Intermediate acting methylphenidates
ritalin SR
short acting methylphenidate
ritalin
long acting stimulant duration of action
10-12hr
intermediate acting stimulant duration of actin
6-8hr
short acting stimualnt duration of action
3-4hr
Which med is the best starting choice for pts age 5-18 + why
Methylphenidates- similar efficacy + better tolerability vs amphetamines
do amphetamines or methylphenidates exacerbate tics more
amphetamines
amphetamine MOA
block NET + DAT, unlike MPH is transported inside the neuron and blocks vesicular reuptake pumps which decrease DA/NE storage and increases intraneuronal dopamine and NE which then spills out into synaptic cleft via channels
long acting amphetamine ex
adderall xr, vyvanse
intermediate acting amphetamine ex
dexedrine spansules
short acting amphetamine ex
dexedrine tab
which med is first line in adults and why
amphetamines - slightly better efficacy, equal tolerability
lisdexamphetamine specific characteristics of metabolism/absorption
prodrug of dextroamphetamine
not active- undergoes enzymatic cleavage in intestinal wall to dextroamphetamine and lysine and is absorbed
onset of effect of vyvanse
2hr
atomoxetine moa
selective NRI (or NET inhibitor)
Why does atomoxetine have less abuse potential
does not increase DA or NE in the nucleus accumbens/mesolimbic tract because there are few NETs present there and therefore no abuse potential
duration of action of atomoxetine
24hr
onset of EFFECT of atomoxetine
2-4wks
bupropion moa
NDRI- increases NE and DA transmission in PFC by blocking NET. increases DA transmission in nucleus accumbens by blocking DAT
cons of bupropion
can cause and exacerbate tics
causes insomnia
dose related seizure risk
doesnt work as well or as fast as stimulants
who is it a good idea to use bupropion in
ADHD and comorbid depression
Alpha 2 agonists work on the _____ synaptic receptor
post
Alpha 2 agonist moa
potentiate the effect of NE in PFC
when are alpha 2 agonists used
monotx or adjunct to stimulants (for aggression, tics, comorbid ODD- dont work well in adults)
alternative in children/adolescents unresponsive or intolerant to stimulant meds
What sx do alpha 2 agonists work for
hyperactivity, impulsivity
differences in guanfacine and clonidine
guanfacine in selective for alpha 2A
guanfacine has longer DOA, dosed once daily
less ae in guanfacine like sedation bc its more selective
First line agents (CADDRA guidelines)
stimulants (MPH and DEX products)
atomoxetine?
second line agents (CADDRA guidelines)
intermediate and short acting stimulants
third line agents (CADDRA guidelines)
Antidepressants (desipramine, nortriptyline, imipramine, bupropion, venlafaxine)
post synaptic alpha 2 agonists
best suggested use for atomoxetine
poor response or tolerability to stimulants or co morbid substance abuse, anxiety, tics, psychosis
1st line management of ADHD for 4-5 yr olds
behavior tx alone, then stimulants if poor response
which meds can be sprinkled on soft food or diluted in water
adderall XR, dexedrine spansules, biphentin, foquest- sprinkle beads on apple sauce
vyvanse- open caps and dilute in water/OJ/yogurt- chew tabs aswell
Onset of effect for anti depressants/alpha 2 agonists
2-4wks
Benefits of long acting agents
once daily admin= less flux in serum conc
less rebound
improved adherence
avoid having to take meds at school
Cons of long acting agents
may affect evening appetite and sleep
some may still require IR product in afternoon to control evening Sx or in the morning to get faster onset of effect
Pro of short acting agents
offer dosage flexibility during Tx initiation
useful as an add on to longer acting agent (ex: to control evening sx, to provide faster morning onset of effect)
What to do if tics appear/worsen on stimulants
switch to MPH if on DEX- if on MPH: atomoxetine, imipramine is an option
Tx tics with risperidone or alpha agonist
D/c + rechallenge
meds to consider with someone with substance abuse
strattera, bupropion, vyvanse, concerta
longer acting may have lower abuse potential but avoid stimulants in pt with known or suspected substance abuse or drug diversion
meds to use with comorbid mood disorders or anxiety
atomoxotine or antidepressants (may adress both or be used as adjunct to stimulants)
meds to avoid with psychosis
stimulants, bupropion
meds to avoid with bipolar/anxiety
stimulants, atomoxetine
safer choices for pts with psychiatric/neurologic comorbidities
clonidine and guanfacine
undesirable effects with clonidine/guanfacine
tx emergent irritability, depression, nightmares
CV risk with ADHD meds
rare but serious CV events (SCD, MI, stroke, arrythmias, syncope, chest pain) have occured in users of stimulants, atmoxetine, MPH/clonidine combo
stimulants/atomoxetine are sympathomimetic agents and can cause small but significant increases in BP, HR and potentially increase risk for SCD
stimulant dosing tips
start low and increase weekly by the same amount until improvement or intolerable SE occur
weight based dosing not used
ritalin dose no later than 4pm
atomoxetine dosing tips
children weight based dosing
may be prescribed bid morning and late afternoon to improve tolerability
How to tell if Tx is working
document baseline Sx over 1/12 pre med period with goal to identify 3-6 target outcomes that are reliable and can be measured
collateral history from parents/teachers
rating scales aviailable
monitor for improvement in frequency and severity of core Sx (attention, hyperactivity, impulsivity)
other concerns like reading, social skills, academics may not improve
goal to alleviate sx and improve fxning at home/work/school- less disruptive, sit still, pay attn, etc
what to do if tx isnt working
confirm diagnosis, check adherence, alter dose/dose schedule, switch
how to manage insomnia
avoid giving stimulants too late in day
consider using shorter acting formulation
melatonin 3-6mg 30min-2hr at sunset
benzos, zopiclone in adults
how to manage rebound hyperactivity
use long acting stimulant or more frequent dosing of short acting, switch to non-stim like atomoxetine
how to manage appetite suppression and weight loss
take med with/after breakfast
high calorie meal closer to the end of day
switch to whole milk
prep nutritious snacks
encourage child to eat when hungry
high calorie drinks- breakfast drinks, boost
if weight loss >10% switch nonstim
growth suppression effects from stimulants
extent to which long term stim use results in height/weight deficits is unclear
1cm/yr for first 1-3yrs noted, overall potentially a 0.5-1inch deficit overall
dont do drug holiday
monitor with atomoxetine aswell
how to manage headaches
tx with mild analgesics (tylenol/nsaids)
usually dissapates when on stable dose for a few wks
atomoxetine specific ae
hepatoxicity (jaundice, LFTs 40x ULN)- rare case reports and recover with d/c drug
sexual dysfxn
increased suicidality
how long to tx adhd
no consensus- 1/3 of chidlrens sx get better in adulthood. medication may not be needed long term but many will benefit
how to assess if you still need adhd meds
gradual withdrawal when school is in season
how to d/c stimulants
stimulants used for >3mo should be tapered over 2-4wks
D isomer of amphetamine is more potent for…
DAT
L isomer of amphetamine is more potent for
NET